Respiratory infections: Do we ever recover?

Proceedings of the American Thoracic Society

Volumn 4, Issue 8, 2007, Pages 618-625

  Goulding, John ^a   Snelgrove, Robert ^a   Saldana, José ^a   Didierlaurent, Arnaud ^a   Cavanagh, Mary ^a   Gwyer, Emily ^a   Wales, Jeremy ^a   Wissinger, Erika L ^a   Hussell, Tracy ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Heterologous immunity; Influenza; Innate immunity; Lung inflammation; Respiratory tract

Indexed keywords

ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BACTERIAL PNEUMONIA; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; INFLAMMATION; INFLUENZA; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGEN-PRESENTING CELLS; CROSS REACTIONS; EPITHELIAL CELLS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHATIC SYSTEM; REGENERATION; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES;

EID: 37349113352     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200706-066TH     Document Type: Article

References (107)

1. Takabayshi K, Corr M, Hayashi T, Redecke V, Beck L, Guiney D, Sheppard D, Raz E. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 2006;24:475-487.
2. Hammad H, Lambrecht BN. Lung dendritic cell migration. Adv Immunol 2007;93:265-278.
3. Barclay AN, Wright GJ, Brooke G, Brown MH. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002;23:285-290.
4. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S, Woodland DL, Lund FE, Randall TD. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004;10:927-934.
5. Humphreys IR, Walzl G, Edwards L, Rae A, Hill S, Hussell T. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med 2003;198:1237-1242.
6. Hussell T, Snelgrove R, Humphreys IR, Williams AE. Co-stimulation: novel methods for preventing viral-induced lung inflammation. Trends Mol Med 2004;10:379-386.
7. Hussell T, Pennycook A, Openshaw PJM. Inhibition of tumour necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 2001;31:2566-2573.
8. Humphreys IR, Edwards L, Snelgrove RJ, Rae AJ, Coyle AJ, Hussell T. A critical role for ICOS co-stimulation in immune containment of pulmonary influenza virus infection. Eur J Immunol 2006;36:2928-2938.
9. Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, Welsh RM. Memory of mice and men: CD81 T-cell cross-reactivity and heterologous immunity. Immunol Rev 2006;211:164-181.
10. Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trends Immunol 2005;26:260-267.
11. Walzl G, Tafuro S, Moss P, Openshaw PJ, Hussell T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J Exp Med 2000;192:1317-1326.
12. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001;2:1067-1076.
13. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 2003;163:1341-1355.
14. Walzl G, Humphreys IR, Marshall BG, Edwards L, Openshaw PJ, Shaw RJ, Hussell T. Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent manner. Infect Immun 2003;71:3384-3391.
15. Edwards L, Williams AE, Krieg AM, Rae AJ, Snelgrove RJ, Hussell T. Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner. Eur J Immunol 2005;35:273-281.
16. Williams AE, Edwards L, Humphreys IR, Snelgrove R, Rae A, Rappuoli R, Hussell T. Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol 2004;173:7435-7443.
17. Maizels RM. Infections and allergy: helminths, hygiene and host immune regulation. Curr Opin Immunol 2005;17:656-661.
18. Furze RC, Hussell T, Selkirk ME. Amelioration of influenza-induced pathology in mice by coinfection with Trichinella spiralis. Infect Immun 2006;74:1924-1932.
19. Williams AE, Edwards L, Hussell T. Colonic bacterial infection abrogates eosinophilic pulmonary disease. J Infect Dis 2006;193:223-230.
20. Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, Antignac A, Deghmane AE, Huerre M. van der WS, Taha MK. A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol Lett 2003;222:99-106.
21. van der Sluijs KF, Nijhuis M, Levels JH, Florquin S, Mellor AL, Jansen HM. van Der PT, Lutter R. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 2006;193:214-222.
22. Rook GA, Dheda K, Zumla A. Immune systems in developed and developing countries: implications for the design of vaccines that will work where BCG does not. Tuberculosis (Edinb) 2006;86:152-162.
23. Wolf AJ, Linas B, Trevejo-Nunez GJ, Kincaid E, Tamura T, Takatsu K, Ernst JD. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007;179:2509-2519.
24. Rey-Ladino J, Jiang X, Gabel BR, Shen C, Brunham RC. Survival of Chlamydia muridarum within dendritic cells. Infect Immun 2007;75:3707-3714.
25. Hogg JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001;164:S71-S75.
26. Vitalis TZ, Kern I, Croome A, Behzad H, Hayashi S, Hogg JC. The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur Respir J 1998;11:664-669.
27. Higashimoto Y, Yamagata Y, Itoh H. Complex effect of adenovirus early region proteins on innate immune system. Inflamm Allergy Drug Targets 2006;5:229-237.
28. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007;447:326-329.
29. Schwarze J, O'Donnell DR, Rohwedder A, Openshaw PJ. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004;169:801-805.
30. Guerrero-Plata A, Ortega E, Ortiz-Navarrete V, Gomez B. Antigen presentation by a macrophage-like cell line persistently infected with respiratory syncytial virus. Virus Res 2004;99:95-100.
31. Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:639-643.
32. Kling S, Donninger H, Williams Z, Vermeulen J, Weinberg E, Latiff K, Ghildyal R, Bardin P. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy 2005;35:672-678.
33. Dubrovina TY, Ivanova IA, Shidlovskaya NK, Polyak RY. Significance of long lasting persistence of influenza virus antigens at the portal of infection and in the spleen of mice. Acta Virol 1992;36:450-458.
34. Bramley AM, Vitalis TZ, Wiggs BR, Hegele RG. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea pigs. Eur Respir J 1999;14:1061-1067.
35. Eichelberger MC, Wang ML, Allan W, Webster RG, Doherty PC. Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4 depleted mice. J Gen Virol 1991;72:1695-1698.
36. Hoffmann JA, Reichhart JM. Drosophila innate immunity: an evolutionary perspective. Nat Immunol 2002;3:121-126.
37. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004;39:687-699.
38. Landis GN, Tower J. Superoxide dismutase evolution and life span regulation. Mech Ageing Dev 2005;126:365-379.
39. Zerofsky M, Harel E, Silverman N, Tatar M. Aging of the innate immune response in Drosophila melanogaster. Aging Cell 2005;4:103-108.
40. Moret Y, Siva-Jothy MT. Adaptive innate immunity? Responsivemode prophylaxis in the mealworm beetle, Tenebrio molitor. Proc Biol Sci 2003;270:2475-2480.
41. Lowenberger CA, Kamal S, Chiles J, Paskewitz S, Bulet P, Hoffmann JA, Christensen BM. Mosquito-Plasmodium interactions in response to immune activation of the vector. Exp Parasitol 1999;91:59-69.
42. Kurtz J, Franz K. Innate defence: evidence for memory in invertebrate immunity. Nature 2003;425:37-38.
43. Pham LN, Dionne MS, Shirasu-Hiza M, Schneider DS. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog 2007;3:e26.
44. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003;187:1000-1009.
45. Hakansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun 1994;62:2707-2714.
46. Bai TR, Knight DA. Structural changes in the airways in asthma: observations and consequences. Clin Sci (Lond) 2005;108:463-477.
47. Groskreutz DJ, Monick MM, Powers LS, Yarovinsky TO, Look DC, Hunninghake GW. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol 2006;176:1733-1740.
48. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and in-fluenza A virus. J Biol Chem 2005;280:5571-5580.
49. Miettinen M, Sareneva T, Julkunen I, Matikainen S. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun 2001;2:349-355.
50. Dessing MC, Knapp S, Florquin S, de Vos AF. van Der PT. CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. Am J Respir Crit Care Med 2007;175:604-611.
51. Ratner AJ, Lysenko ES, Paul MN, Weiser JN. Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci USA 2005;102:3429-3434.
52. Torday JS, Rehan VK. The evolutionary continuum from lung development to homeostasis and repair. Am J Physiol Lung Cell Mol Physiol 2007;292:L608-L611.
53. Lamb D, Reid L. Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to sulphur dioxide. J Pathol Bacteriol 1968;96:97-111.
54. Lamb D, Reid L. Goblet cell increase in rat bronchial epithelium after exposure to cigarette and cigar tobacco smoke. BMJ 1969;1:33-35.
55. Hotchkiss JA, Evans WA, Chen BT, Finch GL, Harkema JR. Regional differences in the effects of mainstream cigarette smoke on stored mucosubstances and DNA synthesis in F344 rat nasal respiratory epithelium. Toxicol Appl Pharmacol 1995;131:316-324.
56. Harkema JR, Hotchkiss JA. In vivo effects of endotoxin on intraepithelial mucosubstances in rat pulmonary airways: quantitative histochemistry. Am J Pathol 1992;141:307-317.
57. Steiger D, Hotchkiss J, Bajaj L, Harkema J, Basbaum C. Concurrent increases in the storage and release of mucin-like molecules by rat airway epithelial cells in response to bacterial endotoxin. Am J Respir Cell Mol Biol 1995;12:307-314.
58. Tesfaigzi Y, Harris JF, Hotchkiss JA, Harkema JR. DNA synthesis and Bcl-2 expression during development of mucous cell metaplasia in airway epithelium of rats exposed to LPS. Am J Physiol Lung Cell Mol Physiol 2004;286:L268-L274.
59. Harkema JR, Hotchkiss JA, Barr EB, Bennett CB, Gallup M, Lee JK, Basbaum C. Long-lasting effects of chronic ozone exposure on rat nasal epithelium. Am J Respir Cell Mol Biol 1999;20:517-529.
60. Jamil S, Breuer R, Christensen TG. Abnormal mucous cell phenotype induced by neutrophil elastase in hamster bronchi. Exp Lung Res 1997;23:285-295.
61. Nields HM, Snider GL, Breuer R, Christensen T. Reversible pancreatic elastase-induced bronchial secretory cell metaplasia in the rat. Exp Pathol 1991;41:185-193.
62. Lucey EC, Stone PJ, Christensen TG, Breuer R, Snider GL. An 18-month study of the effects on hamster lungs of intratracheally administered human neutrophil elastase. Exp Lung Res 1988;14:671-686.
63. Wright JL, Lawson LM, Pare PD, Wiggs BJ, Kennedy S, Hogg JC. Morphology of peripheral airways in current smokers and ex-smokers. Am Rev Respir Dis 1983;127:474-477.
64. Andley UP, Spector A. Peroxide resistance in human and mouse lens epithelial cell lines is related to long-term changes in cell biology and architecture. Free Radic Biol Med 2005;39:797-810.
65. Gebb S, Stevens T. On lung endothelial cell heterogeneity. Microvasc Res 2004;68:1-12.
66. Thorin E, Shreeve SM. Heterogeneity of vascular endothelial cells in normal and disease states. Pharmacol Ther 1998;78:155-166.
67. Cid MC. Endothelial cell biology, perivascular inflammation, and vasculitis. Cleve Clin J Med 2002;69:SII45-SII49.
68. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002;106:184-190.
69. Spier SA, Delp MD, Stallone JN, Dominguez JM, Muller-Delp JM. Exercise training enhances flow-induced vasodilation in skeletal muscle resistance arteries of aged rats: role of PGI2 and NO. Am J Physiol Heart Circ Physiol 2007;292:H3119-H3127.
70. Xu T, Qiao J, Zhao L, Wang G, He G, Li K, Tian Y, Gao M, Wang J, Wang H, et al. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med 2006;174:1011-1017.
71. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005;115:247-257.
72. Suda T, Chida K, Hayakawa H, Imokawa S, Iwata M, Nakamura H, Sato A. Development of bronchus-associated lymphoid tissue in chronic hypersensitivity pneumonitis. Chest 1999;115:357-363.
73. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116:3183-3194.
74. Pawelec G, Solana R, Remarque E, Mariani E. Impact of aging on innate immunity. J Leukoc Biol 1998;64:703-712.
75. Krishnaraj R, Svanborg A. Preferential accumulation of mature NK cells during human immunosenescence. J Cell Biochem 1992;50:386-391.
76. Mariani E, Roda P, Mariani AR, Vitale M, Degrassi A, Papa S, Facchini A. Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Clin Exp Immunol 1990;81:479-484.
77. Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, Nomura T. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997;84:269-275.
78. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004;5:337-343.
79. Beyer M, Bartz H, Horner K, Doths S, Koerner-Rettberg C, Schwarze J. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J Allergy Clin Immunol 2004;113:127-133.
80. Kirby A, Newton D, Carding S, Kaye P. Pulmonary dendritic cells and alveolar macrophages are regulated by gammadelta T cells during the resolution of S. pneumoniae-induced inflammation. J Pathol 2007;212:22-37.
81. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003;3:984-993.
82. Juffermans NP, Leemans JC, Florquin S, Verbon A, Kolk AH, Speelman P, van Deventer SJ. van Der PT. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis. Infect Immun 2002;70:147-152.
83. Legge KL, Braciale TJ. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 2003;18:265-277.
84. Myrvik QN, Leake ES, Fariss B. Lysozyme content of alveolar and peritoneal macrophages from the rabbit. J Immunol 1961;86:133-136.
85. Thepen T, Kraal G, Holt PG. The role of alveolar macrophages in regulation of lung inflammation. Ann N Y Acad Sci 1994;725:200-206.
86. Lipscomb MF, Pollard AM, Yates JL. A role for TGF-beta in the suppression by murine bronchoalveolar cells of lung dendritic cell initiated immune responses. Reg Immunol 1993;5:151-157.
87. Chelen CJ, Fang Y, Freeman GJ, Secrist H, Marshall JD, Hwang PT, Frankel LR, DeKruyff RH, Umetsu DT. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995;95:1415-1421.
88. Balbo P, Silvestri M, Rossi GA, Crimi E, Burastero SE. Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin Exp Allergy 2001;31:625-636.
89. Bilyk N, Holt PG. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J Exp Med 1993;177:1773-1777.
90. Amano H, Morimoto K, Senba M, Wang H, Ishida Y, Kumatori A, Yoshimine H, Oishi K, Mukaida N, Nagatake T. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J Immunol 2004;172:398-409.
91. Kirby AC, Raynes JG, Kaye PM. CD11b regulates recruitment of alveolar macrophages but not pulmonary dendritic cells after pneumococcal challenge. J Infect Dis 2006;193:205-213.
92. Torday JS, Rehan VK. The evolutionary continuum from lung development to homeostasis and repair. Am J Physiol Lung Cell Mol Physiol 2007;292:L608-L611.
93. Ueda Y, Liao D, Yang K, Patel A, Kelsoe G. T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J Immunol 2007;178:3593-3601.
94. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000;288:2222-2226.
95. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005;26:347-362.
96. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA, Herzenberg LA. Innate and acquired humoral immunities to in-fluenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 1999;96:2250-2255.
97. Claflin JL, Berry J. Genetics of the phosphocholine-specific antibody response to Streptococcus pneumonia: germ-line but not mutated T15 antibodies are dominantly selected. J Immunol 1988;141:4012-4019.
98. Herzenberg LA, Baumgarth N, Wilshire JA. B-1 cell origins and VH repertoire determination. Curr Top Microbiol Immunol 2000;252:3-13.
99. Wu LC, Tuot DS, Lyons DS, Garcia KC, Davis MM. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature 2002;418:552-556.
100. Mason D. A very high level of crossreactivity is an essential feature of the T cell receptor. Immunol Today 1998;19:395-404.
101. Welsh RM, Selin LK, Szomolanyi-Tsuda E. Immunological memory to viral infections. Annu Rev Immunol 2004;22:711-743.
102. Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279:1344-1347.
103. Barnett LA, Fujinami RS. Molecular mimicry: a mechanism for autoimmune injury. FASEB J 1992;6:840-844.
104. Bahl K, Kim SK, Calcagno C, Ghersi D, Puzone R, Celada F, Selin LK, Welsh RM. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol 2006;176:4284-4295.
105. Chapdelaine Y, Smith DK, Pedras-Vasconcelos JA, Krishnan L, Sad S. Increased CD8+ T cell memory to concurrent infection at the expense of increased erosion of pre-existing memory: the paradoxical role of IL-15. J Immunol 2003;171:5454-5460.
106. Sad S, Krishnan L. Maintenance and attrition of T-cell memory. Crit Rev Immunol 2003;23:129-147.
107. Smith DK, Dudani R, Pedras-Vasconcelos JA, Chapdelaine Y, van Faassen H, Sad S. Cross-reactive antigen is required to prevent erosion of established T cell memory and tumor immunity: a heterologous bacterial model of attrition. J Immunol 2002;169:1197-1206.